Heart Health, Inc.
PINK SHEETS : HHEL

Heart Health, Inc.

June 19, 2008 12:35 ET

Heart Health, Inc. Board of Directors Approves Capital Restructuring

MONTREAL, QUEBEC--(Marketwire - June 19, 2008) - Heart Health, Inc. (OTCPK:HHEL) has announced that its Board of Directors has approved a 200-1 reverse split of the Company's common stock for all shareholders of record as of June 19, 2008. The Company has received approval from the Financial Industry Regulatory Authority (FINRA) for the restructuring, and has issued a new symbol, HHEL, under which the stock will be trading as of June 19, 2008.

The capital restructuring is being implemented as a means to better position the Company for investment and to raise additional capital for product research and development. Each 200 shares of common stock converts into one share of the new common stock, trading under the new symbol, HHEL.

"We envision that the restructuring will allow us to improve our stock price in order to foster investment for the research and development of our Heart Health Monitor and other products that the Company may acquire. We are confident in our ability to continue to improve and develop our distinctive cardiovascular devices and build shareholder confidence," stated Michael Kron, Chairman and CEO of Heart Health, Inc.

Heart Health, Inc. recently announced the signing of Dr. Hyman Reisler, an experienced cardiologist, to its advisory board. Dr. Reisler was signed to the newly formed advisory board to give opinions in the field of cardiology, which will enable the Company to better serve its customers. The Heart Health Monitor (HHM) is currently under redevelopment to provide added benefits such as BlueTooth and USB capabilities.

About Heart Health, Inc.:

Heart Health, Inc. is a holding company focused on the development and marketing of innovative, cardiovascular medical device products. The Company intends to revolutionize the way in which people monitor the health of their hearts using newly acquired products such as the Heart Health Monitor.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact Information

  • Heart Health, Inc.
    Investor Relations
    1 866 THE APPL(E)